Experimental approaches
Serova Bio
Serova Bio researches personalized mRNA cancer vaccines. Its vaccines are investigational and unapproved.
Serova Bio researches personalized mRNA cancer vaccines. The company was preparing for a formal launch as of October 2026.
Its vaccines are investigational and unapproved.